Fibroblast Growth Factor 23 and Osteoporosis: Evidence from Bench to Bedside

Osteoporosis is a chronic debilitating disease caused by imbalanced bone remodeling processes that impair the structural integrity of bone. Over the last ten years, the association between fibroblast growth factor 23 (FGF23) and osteoporosis has been studied in both pre-clinical and clinical investi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sirikul, Wachiranun, Siri-Angkul, Natthaphat, Chattipakorn, Nipon, Chattipakorn, Siriporn C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909928/
https://www.ncbi.nlm.nih.gov/pubmed/35269640
http://dx.doi.org/10.3390/ijms23052500

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909928/
https://www.ncbi.nlm.nih.gov/pubmed/35269640
http://dx.doi.org/10.3390/ijms23052500

Ejemplares similares